FdaApplication
ANDA 202025
Identifiers
- fda_app_no: ANDA202025
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS |
| application_type | ANDA |
| approval_date | 2013-02-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 20MG BASE | TABLET;ORAL |
1 product